APO Research
Talk to an analyst

APO RESEARCH · REPORT

Spatial Proteomics and Transcriptomics Services

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Spatial Proteomics and Transcriptomics Services Market Outlook and Growth Opportunities 2026

12 August 2026217 pages

Choose your research edition.

Industry ResearchSpatial Proteomics and Transcriptomics Services Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Spatial Proteomics and Transcriptomics Services Industry Growth and Trends Forecast to 2032122 pages · $3,450 USDMarket StructureGlobal Spatial Proteomics and Transcriptomics Services Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Spatial Proteomics and Transcriptomics Services Market Outlook and Growth Opportunities 2026217 pages · $4,250 USDMarket Analysis & ForecastGlobal Spatial Proteomics and Transcriptomics Services Market Analysis and Forecast 2026-2032192 pages · $4,950 USD

Market perspective

The global Spatial Proteomics and Transcriptomics Services market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Spatial Proteomics and Transcriptomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Spatial Proteomics and Transcriptomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Spatial Proteomics and Transcriptomics Services is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Spatial Proteomics and Transcriptomics Services market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Spatial Proteomics and Transcriptomics Services market include CellCarta, APTBIO, Vizgen, PTM BIO, Crown Bioscience, Biodesix, BGI Genomics, Shanghai OE Biotech and Westlake Omics, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Spatial Proteomics and Transcriptomics Services market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Spatial Proteomics and Transcriptomics Services and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Spatial Proteomics and Transcriptomics Services revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Spatial Proteomics and Transcriptomics Services market.

Spatial Proteomics and Transcriptomics Services Segment by Company

CellCarta

APTBIO

Vizgen

PTM BIO

Crown Bioscience

Biodesix

BGI Genomics

Shanghai OE Biotech

Westlake Omics

MRM Proteomics

Shanghai Bioprofile

Creative Proteomics

MtoZ-Biolabs

Lc-Bio Technologies

Labcorp

Precision Biomarker Laboratories (PBL)

Metware Biotechnology

Cosmos Wisdom

MS Bioworks

Quanterix

CD Genomics

Discovery Life Sciences

Syncell

Illumina

Psomagen

GENEWIZ (Azenta Life Sciences)

Novogene

Creative Bioarray

SeqMatic

Standard Biotools

Bruker Spatial Biology

BostonGene

Spatial Proteomics and Transcriptomics Services Segment by Type

Spatial Proteomics Services

Spatial Transcriptomics Services

Spatial Proteomics and Transcriptomics Services Segment by Application

Clinical Diagnostics

Drug Discovery

Others

Spatial Proteomics and Transcriptomics Services Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Spatial Proteomics and Transcriptomics Services status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Spatial Proteomics and Transcriptomics Services key companies, revenue, market share, and recent developments.

3. To split the Spatial Proteomics and Transcriptomics Services breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Spatial Proteomics and Transcriptomics Services market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Spatial Proteomics and Transcriptomics Services significant trends, drivers, influence factors in global and regions.

6. To analyze Spatial Proteomics and Transcriptomics Services competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Spatial Proteomics and Transcriptomics Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Spatial Proteomics and Transcriptomics Services and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Spatial Proteomics and Transcriptomics Services.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Spatial Proteomics and Transcriptomics Services industry.

Chapter 3: Detailed analysis of Spatial Proteomics and Transcriptomics Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Spatial Proteomics and Transcriptomics Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Spatial Proteomics and Transcriptomics Services in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Spatial Proteomics and Transcriptomics Services Industry Trends Table 2. Spatial Proteomics and Transcriptomics Services Industry Drivers Table 3. Spatial Proteomics and Transcriptomics Services Industry Opportunities and Challenges Table 4. Spatial Proteomics and Transcriptomics Services Industry Restraints Table 5. Global Spatial Proteomics and Transcriptomics Services Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Spatial Proteomics and Transcriptomics Services Revenue Share by Company (2021-2026) Table 7. Global Spatial Proteomics and Transcriptomics Services Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Spatial Proteomics and Transcriptomics Services Key Company Manufacturing Base & Headquarters Table 9. Global Spatial Proteomics and Transcriptomics Services Company, Product Type & Application Table 10. Global Spatial Proteomics and Transcriptomics Services Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Spatial Proteomics and Transcriptomics Services by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Spatial Proteomics Services Table 15. Significant Companies of Spatial Transcriptomics Services Table 16. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Type (2021-2026) Table 20. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Clinical Diagnostics Table 22. Significant Companies of Drug Discovery Table 23. Significant Companies of Others Table 24. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021-2026) & (US$ Million) Table 26. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2027-2032) & (US$ Million) Table 27. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Application (2021-2026) Table 28. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Application (2027-2032) Table 29. Global Spatial Proteomics and Transcriptomics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2021-2026) & (US$ Million) Table 31. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Region (2021-2026) Table 32. Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2027-2032) & (US$ Million) Table 33. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Region (2027-2032) Table 34. Global Spatial Proteomics and Transcriptomics Services Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Spatial Proteomics and Transcriptomics Services Sales Value by Country (2021-2026) & (US$ Million) Table 36. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by Country (2021-2026) Table 37. Global Spatial Proteomics and Transcriptomics Services Sales Value by Country (2027-2032) & (US$ Million) Table 38. Global Spatial Proteomics and Transcriptomics Services Sales Value Market Share by Country (2027-2032) Table 39. CellCarta Company Information Table 40. CellCarta Business Overview Table 41. CellCarta Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 42. CellCarta Spatial Proteomics and Transcriptomics Services Product Portfolio Table 43. CellCarta Recent Development Table 44. APTBIO Company Information Table 45. APTBIO Business Overview Table 46. APTBIO Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. APTBIO Spatial Proteomics and Transcriptomics Services Product Portfolio Table 48. APTBIO Recent Development Table 49. Vizgen Company Information Table 50. Vizgen Business Overview Table 51. Vizgen Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Vizgen Spatial Proteomics and Transcriptomics Services Product Portfolio Table 53. Vizgen Recent Development Table 54. PTM BIO Company Information Table 55. PTM BIO Business Overview Table 56. PTM BIO Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. PTM BIO Spatial Proteomics and Transcriptomics Services Product Portfolio Table 58. PTM BIO Recent Development Table 59. Crown Bioscience Company Information Table 60. Crown Bioscience Business Overview Table 61. Crown Bioscience Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Crown Bioscience Spatial Proteomics and Transcriptomics Services Product Portfolio Table 63. Crown Bioscience Recent Development Table 64. Biodesix Company Information Table 65. Biodesix Business Overview Table 66. Biodesix Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Biodesix Spatial Proteomics and Transcriptomics Services Product Portfolio Table 68. Biodesix Recent Development Table 69. BGI Genomics Company Information Table 70. BGI Genomics Business Overview Table 71. BGI Genomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. BGI Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 73. BGI Genomics Recent Development Table 74. Shanghai OE Biotech Company Information Table 75. Shanghai OE Biotech Business Overview Table 76. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Product Portfolio Table 78. Shanghai OE Biotech Recent Development Table 79. Westlake Omics Company Information Table 80. Westlake Omics Business Overview Table 81. Westlake Omics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Westlake Omics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 83. Westlake Omics Recent Development Table 84. MRM Proteomics Company Information Table 85. MRM Proteomics Business Overview Table 86. MRM Proteomics Spatial Proteomics and Transcriptomics Services Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. MRM Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 88. MRM Proteomics Recent Development Table 89. Shanghai Bioprofile Company Information Table 90. Shanghai Bioprofile Business Overview Table 91. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Product Portfolio Table 93. Shanghai Bioprofile Recent Development Table 94. Creative Proteomics Company Information Table 95. Creative Proteomics Business Overview Table 96. Creative Proteomics Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Creative Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 98. Creative Proteomics Recent Development Table 99. MtoZ-Biolabs Company Information Table 100. MtoZ-Biolabs Business Overview Table 101. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 102. MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Product Portfolio Table 103. MtoZ-Biolabs Recent Development Table 104. Lc-Bio Technologies Company Information Table 105. Lc-Bio Technologies Business Overview Table 106. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 107. Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Product Portfolio Table 108. Lc-Bio Technologies Recent Development Table 109. Labcorp Company Information Table 110. Labcorp Business Overview Table 111. Labcorp Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 112. Labcorp Spatial Proteomics and Transcriptomics Services Product Portfolio Table 113. Labcorp Recent Development Table 114. Precision Biomarker Laboratories (PBL) Company Information Table 115. Precision Biomarker Laboratories (PBL) Business Overview Table 116. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 117. Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Product Portfolio Table 118. Precision Biomarker Laboratories (PBL) Recent Development Table 119. Metware Biotechnology Company Information Table 120. Metware Biotechnology Business Overview Table 121. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 122. Metware Biotechnology Spatial Proteomics and Transcriptomics Services Product Portfolio Table 123. Metware Biotechnology Recent Development Table 124. Cosmos Wisdom Company Information Table 125. Cosmos Wisdom Business Overview Table 126. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 127. Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Product Portfolio Table 128. Cosmos Wisdom Recent Development Table 129. MS Bioworks Company Information Table 130. MS Bioworks Business Overview Table 131. MS Bioworks Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 132. MS Bioworks Spatial Proteomics and Transcriptomics Services Product Portfolio Table 133. MS Bioworks Recent Development Table 134. Quanterix Company Information Table 135. Quanterix Business Overview Table 136. Quanterix Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 137. Quanterix Spatial Proteomics and Transcriptomics Services Product Portfolio Table 138. Quanterix Recent Development Table 139. CD Genomics Company Information Table 140. CD Genomics Business Overview Table 141. CD Genomics Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 142. CD Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio Table 143. CD Genomics Recent Development Table 144. Discovery Life Sciences Company Information Table 145. Discovery Life Sciences Business Overview Table 146. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 147. Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Product Portfolio Table 148. Discovery Life Sciences Recent Development Table 149. Syncell Company Information Table 150. Syncell Business Overview Table 151. Syncell Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 152. Syncell Spatial Proteomics and Transcriptomics Services Product Portfolio Table 153. Syncell Recent Development Table 154. Illumina Company Information Table 155. Illumina Business Overview Table 156. Illumina Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 157. Illumina Spatial Proteomics and Transcriptomics Services Product Portfolio Table 158. Illumina Recent Development Table 159. Psomagen Company Information Table 160. Psomagen Business Overview Table 161. Psomagen Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 162. Psomagen Spatial Proteomics and Transcriptomics Services Product Portfolio Table 163. Psomagen Recent Development Table 164. GENEWIZ (Azenta Life Sciences) Company Information Table 165. GENEWIZ (Azenta Life Sciences) Business Overview Table 166. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 167. GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Product Portfolio Table 168. GENEWIZ (Azenta Life Sciences) Recent Development Table 169. Novogene Company Information Table 170. Novogene Business Overview Table 171. Novogene Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 172. Novogene Spatial Proteomics and Transcriptomics Services Product Portfolio Table 173. Novogene Recent Development Table 174. Creative Bioarray Company Information Table 175. Creative Bioarray Business Overview Table 176. Creative Bioarray Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 177. Creative Bioarray Spatial Proteomics and Transcriptomics Services Product Portfolio Table 178. Creative Bioarray Recent Development Table 179. SeqMatic Company Information Table 180. SeqMatic Business Overview Table 181. SeqMatic Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 182. SeqMatic Spatial Proteomics and Transcriptomics Services Product Portfolio Table 183. SeqMatic Recent Development Table 184. Standard Biotools Company Information Table 185. Standard Biotools Business Overview Table 186. Standard Biotools Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 187. Standard Biotools Spatial Proteomics and Transcriptomics Services Product Portfolio Table 188. Standard Biotools Recent Development Table 189. Bruker Spatial Biology Company Information Table 190. Bruker Spatial Biology Business Overview Table 191. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 192. Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Product Portfolio Table 193. Bruker Spatial Biology Recent Development Table 194. BostonGene Company Information Table 195. BostonGene Business Overview Table 196. BostonGene Spatial Proteomics and Transcriptomics Services Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 197. BostonGene Spatial Proteomics and Transcriptomics Services Product Portfolio Table 198. BostonGene Recent Development Table 199. Research Programs/Design for This Report Table 200. Authors List of This Report Table 201. Secondary Sources Table 202. Primary Sources List of Figures Figure 1. Spatial Proteomics and Transcriptomics Services Product Image Figure 2. Global Spatial Proteomics and Transcriptomics Services Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Spatial Proteomics and Transcriptomics Services Market Size (2021-2032) & (US$ Million) Figure 4. Global Spatial Proteomics and Transcriptomics Services Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Spatial Proteomics Services Image Figure 8. Spatial Transcriptomics Services Image Figure 9. Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Spatial Proteomics and Transcriptomics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Type (2021-2032) Figure 12. Clinical Diagnostics Image Figure 13. Drug Discovery Image Figure 14. Others Image Figure 15. Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Spatial Proteomics and Transcriptomics Services Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Application (2021-2032) Figure 18. Global Spatial Proteomics and Transcriptomics Services Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 19. Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 20. North America Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032) & (US$ Million) Figure 21. North America Spatial Proteomics and Transcriptomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 22. Europe Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032) & (US$ Million) Figure 23. Europe Spatial Proteomics and Transcriptomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 24. Asia-Pacific Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032) & (US$ Million) Figure 25. Asia-Pacific Spatial Proteomics and Transcriptomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 26. South America Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032) & (US$ Million) Figure 27. South America Spatial Proteomics and Transcriptomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032) & (US$ Million) Figure 29. Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value Share by Country (%), 2025 VS 2032 Figure 30. USA Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 31. USA Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 32. USA Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 33. Canada Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 34. Canada Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 35. Canada Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 36. Mexico Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 37. Mexico Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 38. Mexico Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 39. Germany Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. Germany Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. Germany Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. France Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. France Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. France Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. U.K. Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. U.K. Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. U.K. Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Italy Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Italy Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Italy Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Spain Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Spain Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Spain Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. Russia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. Russia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. Russia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. China Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. China Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. China Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Japan Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Japan Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Japan Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. South Korea Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. South Korea Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. South Korea Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. India Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. India Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. India Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Australia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Australia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Australia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. Brazil Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. Brazil Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. Brazil Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Argentina Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Argentina Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Argentina Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Chile Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Chile Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Chile Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Colombia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Colombia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Colombia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Peru Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Peru Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Peru Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Israel Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Israel Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Israel Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. UAE Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. UAE Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. UAE Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Turkey Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Turkey Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Turkey Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Iran Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Iran Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Iran Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Egypt Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Egypt Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Egypt Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Years Considered Figure 115. Research Process Figure 116. Key Executives Interviewed

Scope & coverage.

Types
  • Spatial Proteomics Services
  • Spatial Transcriptomics Services
Applications
  • Clinical Diagnostics
  • Drug Discovery
  • Others
Companies covered
  • CellCarta
  • APTBIO
  • Vizgen
  • PTM BIO
  • Crown Bioscience
  • Biodesix
  • BGI Genomics
  • Shanghai OE Biotech
  • Westlake Omics
  • MRM Proteomics
  • Shanghai Bioprofile
  • Creative Proteomics
  • MtoZ-Biolabs
  • Lc-Bio Technologies
  • Labcorp
  • Precision Biomarker Laboratories (PBL)
  • Metware Biotechnology
  • Cosmos Wisdom
  • MS Bioworks
  • Quanterix
  • CD Genomics
  • Discovery Life Sciences
  • Syncell
  • Illumina
  • Psomagen
  • GENEWIZ (Azenta Life Sciences)
  • Novogene
  • Creative Bioarray
  • SeqMatic
  • Standard Biotools
  • Bruker Spatial Biology
  • BostonGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Spatial Proteomics and Transcriptomics Services Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Spatial Proteomics and Transcriptomics Services Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Spatial Proteomics and Transcriptomics Services Market Dynamics
  1. 2.1 Spatial Proteomics and Transcriptomics Services Industry Trends
  2. 2.2 Spatial Proteomics and Transcriptomics Services Industry Drivers
  3. 2.3 Spatial Proteomics and Transcriptomics Services Industry Opportunities and Challenges
  4. 2.4 Spatial Proteomics and Transcriptomics Services Industry Restraints
3 Spatial Proteomics and Transcriptomics Services Market by Company
  1. 3.1 Global Spatial Proteomics and Transcriptomics Services Company Revenue Ranking in 2025
  2. 3.2 Global Spatial Proteomics and Transcriptomics Services Revenue by Company (2021-2026)
  3. 3.3 Global Spatial Proteomics and Transcriptomics Services Company Ranking (2024-2026)
  4. 3.4 Global Spatial Proteomics and Transcriptomics Services Company Manufacturing Base and Headquarters
  5. 3.5 Global Spatial Proteomics and Transcriptomics Services Company Product Type and Application
  6. 3.6 Global Spatial Proteomics and Transcriptomics Services Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Spatial Proteomics and Transcriptomics Services Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Spatial Proteomics and Transcriptomics Services Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Spatial Proteomics and Transcriptomics Services Market by Type
  1. 4.1 Spatial Proteomics and Transcriptomics Services Type Introduction
  2. 4.1.1 Spatial Proteomics Services
  3. 4.1.2 Spatial Transcriptomics Services
  4. 4.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Type
  5. 4.2.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Type (2021-2032)
  7. 4.2.3 Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Type (2021-2032)
5 Spatial Proteomics and Transcriptomics Services Market by Application
  1. 5.1 Spatial Proteomics and Transcriptomics Services Application Introduction
  2. 5.1.1 Clinical Diagnostics
  3. 5.1.2 Drug Discovery
  4. 5.1.3 Others
  5. 5.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application
  6. 5.2.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Application (2021-2032)
  8. 5.2.3 Global Spatial Proteomics and Transcriptomics Services Sales Value Share by Application (2021-2032)
6 Spatial Proteomics and Transcriptomics Services Regional Value Analysis
  1. 6.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2021-2032)
  3. 6.2.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region: 2021-2026
  4. 6.2.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032)
  7. 6.3.2 North America Spatial Proteomics and Transcriptomics Services Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032)
  10. 6.4.2 Europe Spatial Proteomics and Transcriptomics Services Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Spatial Proteomics and Transcriptomics Services Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032)
  16. 6.6.2 South America Spatial Proteomics and Transcriptomics Services Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Spatial Proteomics and Transcriptomics Services Sales Value Share by Country, 2025 VS 2032
7 Spatial Proteomics and Transcriptomics Services Country-level Value Analysis
  1. 7.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Country (2021-2032)
  3. 7.2.1 Global Spatial Proteomics and Transcriptomics Services Sales Value by Country (2021-2026)
  4. 7.2.2 Global Spatial Proteomics and Transcriptomics Services Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Spatial Proteomics and Transcriptomics Services Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Spatial Proteomics and Transcriptomics Services Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Spatial Proteomics and Transcriptomics Services Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 CellCarta
  2. 8.1.1 CellCarta Company Information
  3. 8.1.2 CellCarta Business Overview
  4. 8.1.3 CellCarta Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  5. 8.1.4 CellCarta Spatial Proteomics and Transcriptomics Services Product Portfolio
  6. 8.1.5 CellCarta Recent Developments
  7. 8.2 APTBIO
  8. 8.2.1 APTBIO Company Information
  9. 8.2.2 APTBIO Business Overview
  10. 8.2.3 APTBIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  11. 8.2.4 APTBIO Spatial Proteomics and Transcriptomics Services Product Portfolio
  12. 8.2.5 APTBIO Recent Developments
  13. 8.3 Vizgen
  14. 8.3.1 Vizgen Company Information
  15. 8.3.2 Vizgen Business Overview
  16. 8.3.3 Vizgen Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vizgen Spatial Proteomics and Transcriptomics Services Product Portfolio
  18. 8.3.5 Vizgen Recent Developments
  19. 8.4 PTM BIO
  20. 8.4.1 PTM BIO Company Information
  21. 8.4.2 PTM BIO Business Overview
  22. 8.4.3 PTM BIO Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  23. 8.4.4 PTM BIO Spatial Proteomics and Transcriptomics Services Product Portfolio
  24. 8.4.5 PTM BIO Recent Developments
  25. 8.5 Crown Bioscience
  26. 8.5.1 Crown Bioscience Company Information
  27. 8.5.2 Crown Bioscience Business Overview
  28. 8.5.3 Crown Bioscience Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Crown Bioscience Spatial Proteomics and Transcriptomics Services Product Portfolio
  30. 8.5.5 Crown Bioscience Recent Developments
  31. 8.6 Biodesix
  32. 8.6.1 Biodesix Company Information
  33. 8.6.2 Biodesix Business Overview
  34. 8.6.3 Biodesix Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Biodesix Spatial Proteomics and Transcriptomics Services Product Portfolio
  36. 8.6.5 Biodesix Recent Developments
  37. 8.7 BGI Genomics
  38. 8.7.1 BGI Genomics Company Information
  39. 8.7.2 BGI Genomics Business Overview
  40. 8.7.3 BGI Genomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  41. 8.7.4 BGI Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  42. 8.7.5 BGI Genomics Recent Developments
  43. 8.8 Shanghai OE Biotech
  44. 8.8.1 Shanghai OE Biotech Company Information
  45. 8.8.2 Shanghai OE Biotech Business Overview
  46. 8.8.3 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai OE Biotech Spatial Proteomics and Transcriptomics Services Product Portfolio
  48. 8.8.5 Shanghai OE Biotech Recent Developments
  49. 8.9 Westlake Omics
  50. 8.9.1 Westlake Omics Company Information
  51. 8.9.2 Westlake Omics Business Overview
  52. 8.9.3 Westlake Omics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Westlake Omics Spatial Proteomics and Transcriptomics Services Product Portfolio
  54. 8.9.5 Westlake Omics Recent Developments
  55. 8.10 MRM Proteomics
  56. 8.10.1 MRM Proteomics Company Information
  57. 8.10.2 MRM Proteomics Business Overview
  58. 8.10.3 MRM Proteomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  59. 8.10.4 MRM Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  60. 8.10.5 MRM Proteomics Recent Developments
  61. 8.11 Shanghai Bioprofile
  62. 8.11.1 Shanghai Bioprofile Company Information
  63. 8.11.2 Shanghai Bioprofile Business Overview
  64. 8.11.3 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Shanghai Bioprofile Spatial Proteomics and Transcriptomics Services Product Portfolio
  66. 8.11.5 Shanghai Bioprofile Recent Developments
  67. 8.12 Creative Proteomics
  68. 8.12.1 Creative Proteomics Company Information
  69. 8.12.2 Creative Proteomics Business Overview
  70. 8.12.3 Creative Proteomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Creative Proteomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  72. 8.12.5 Creative Proteomics Recent Developments
  73. 8.13 MtoZ-Biolabs
  74. 8.13.1 MtoZ-Biolabs Company Information
  75. 8.13.2 MtoZ-Biolabs Business Overview
  76. 8.13.3 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  77. 8.13.4 MtoZ-Biolabs Spatial Proteomics and Transcriptomics Services Product Portfolio
  78. 8.13.5 MtoZ-Biolabs Recent Developments
  79. 8.14 Lc-Bio Technologies
  80. 8.14.1 Lc-Bio Technologies Company Information
  81. 8.14.2 Lc-Bio Technologies Business Overview
  82. 8.14.3 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Lc-Bio Technologies Spatial Proteomics and Transcriptomics Services Product Portfolio
  84. 8.14.5 Lc-Bio Technologies Recent Developments
  85. 8.15 Labcorp
  86. 8.15.1 Labcorp Company Information
  87. 8.15.2 Labcorp Business Overview
  88. 8.15.3 Labcorp Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Labcorp Spatial Proteomics and Transcriptomics Services Product Portfolio
  90. 8.15.5 Labcorp Recent Developments
  91. 8.16 Precision Biomarker Laboratories (PBL)
  92. 8.16.1 Precision Biomarker Laboratories (PBL) Company Information
  93. 8.16.2 Precision Biomarker Laboratories (PBL) Business Overview
  94. 8.16.3 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Precision Biomarker Laboratories (PBL) Spatial Proteomics and Transcriptomics Services Product Portfolio
  96. 8.16.5 Precision Biomarker Laboratories (PBL) Recent Developments
  97. 8.17 Metware Biotechnology
  98. 8.17.1 Metware Biotechnology Company Information
  99. 8.17.2 Metware Biotechnology Business Overview
  100. 8.17.3 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Metware Biotechnology Spatial Proteomics and Transcriptomics Services Product Portfolio
  102. 8.17.5 Metware Biotechnology Recent Developments
  103. 8.18 Cosmos Wisdom
  104. 8.18.1 Cosmos Wisdom Company Information
  105. 8.18.2 Cosmos Wisdom Business Overview
  106. 8.18.3 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Cosmos Wisdom Spatial Proteomics and Transcriptomics Services Product Portfolio
  108. 8.18.5 Cosmos Wisdom Recent Developments
  109. 8.19 MS Bioworks
  110. 8.19.1 MS Bioworks Company Information
  111. 8.19.2 MS Bioworks Business Overview
  112. 8.19.3 MS Bioworks Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  113. 8.19.4 MS Bioworks Spatial Proteomics and Transcriptomics Services Product Portfolio
  114. 8.19.5 MS Bioworks Recent Developments
  115. 8.20 Quanterix
  116. 8.20.1 Quanterix Company Information
  117. 8.20.2 Quanterix Business Overview
  118. 8.20.3 Quanterix Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Quanterix Spatial Proteomics and Transcriptomics Services Product Portfolio
  120. 8.20.5 Quanterix Recent Developments
  121. 8.21 CD Genomics
  122. 8.21.1 CD Genomics Company Information
  123. 8.21.2 CD Genomics Business Overview
  124. 8.21.3 CD Genomics Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  125. 8.21.4 CD Genomics Spatial Proteomics and Transcriptomics Services Product Portfolio
  126. 8.21.5 CD Genomics Recent Developments
  127. 8.22 Discovery Life Sciences
  128. 8.22.1 Discovery Life Sciences Company Information
  129. 8.22.2 Discovery Life Sciences Business Overview
  130. 8.22.3 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Discovery Life Sciences Spatial Proteomics and Transcriptomics Services Product Portfolio
  132. 8.22.5 Discovery Life Sciences Recent Developments
  133. 8.23 Syncell
  134. 8.23.1 Syncell Company Information
  135. 8.23.2 Syncell Business Overview
  136. 8.23.3 Syncell Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  137. 8.23.4 Syncell Spatial Proteomics and Transcriptomics Services Product Portfolio
  138. 8.23.5 Syncell Recent Developments
  139. 8.24 Illumina
  140. 8.24.1 Illumina Company Information
  141. 8.24.2 Illumina Business Overview
  142. 8.24.3 Illumina Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  143. 8.24.4 Illumina Spatial Proteomics and Transcriptomics Services Product Portfolio
  144. 8.24.5 Illumina Recent Developments
  145. 8.25 Psomagen
  146. 8.25.1 Psomagen Company Information
  147. 8.25.2 Psomagen Business Overview
  148. 8.25.3 Psomagen Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  149. 8.25.4 Psomagen Spatial Proteomics and Transcriptomics Services Product Portfolio
  150. 8.25.5 Psomagen Recent Developments
  151. 8.26 GENEWIZ (Azenta Life Sciences)
  152. 8.26.1 GENEWIZ (Azenta Life Sciences) Company Information
  153. 8.26.2 GENEWIZ (Azenta Life Sciences) Business Overview
  154. 8.26.3 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  155. 8.26.4 GENEWIZ (Azenta Life Sciences) Spatial Proteomics and Transcriptomics Services Product Portfolio
  156. 8.26.5 GENEWIZ (Azenta Life Sciences) Recent Developments
  157. 8.27 Novogene
  158. 8.27.1 Novogene Company Information
  159. 8.27.2 Novogene Business Overview
  160. 8.27.3 Novogene Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  161. 8.27.4 Novogene Spatial Proteomics and Transcriptomics Services Product Portfolio
  162. 8.27.5 Novogene Recent Developments
  163. 8.28 Creative Bioarray
  164. 8.28.1 Creative Bioarray Company Information
  165. 8.28.2 Creative Bioarray Business Overview
  166. 8.28.3 Creative Bioarray Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  167. 8.28.4 Creative Bioarray Spatial Proteomics and Transcriptomics Services Product Portfolio
  168. 8.28.5 Creative Bioarray Recent Developments
  169. 8.29 SeqMatic
  170. 8.29.1 SeqMatic Company Information
  171. 8.29.2 SeqMatic Business Overview
  172. 8.29.3 SeqMatic Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  173. 8.29.4 SeqMatic Spatial Proteomics and Transcriptomics Services Product Portfolio
  174. 8.29.5 SeqMatic Recent Developments
  175. 8.30 Standard Biotools
  176. 8.30.1 Standard Biotools Company Information
  177. 8.30.2 Standard Biotools Business Overview
  178. 8.30.3 Standard Biotools Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  179. 8.30.4 Standard Biotools Spatial Proteomics and Transcriptomics Services Product Portfolio
  180. 8.30.5 Standard Biotools Recent Developments
  181. 8.31 Bruker Spatial Biology
  182. 8.31.1 Bruker Spatial Biology Company Information
  183. 8.31.2 Bruker Spatial Biology Business Overview
  184. 8.31.3 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  185. 8.31.4 Bruker Spatial Biology Spatial Proteomics and Transcriptomics Services Product Portfolio
  186. 8.31.5 Bruker Spatial Biology Recent Developments
  187. 8.32 BostonGene
  188. 8.32.1 BostonGene Company Information
  189. 8.32.2 BostonGene Business Overview
  190. 8.32.3 BostonGene Spatial Proteomics and Transcriptomics Services Revenue and Gross Margin (2021-2026)
  191. 8.32.4 BostonGene Spatial Proteomics and Transcriptomics Services Product Portfolio
  192. 8.32.5 BostonGene Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst